Market Access leaders know this well: success means turning coverage wins into measurable prescribing and patient starts. With payer policies becoming more variable, provider offices burdened by administrative time sinks, and treatment decisions spread across multidisciplinary teams, legacy pull-through approaches no longer deliver sufficient impact. Instead, forward-looking organizations are shifting from transactional execution to integrated, digitally-enabled operating models that ensure access is fully executed—not just approved.
This Best Practices, LLC, report examines how leading biopharma companies are responding by strengthening cross-functional orchestration, standardizing tools and templates, deepening specialty pharmacy and HUB collaboration, and deploying AI-driven insights to anticipate and resolve access barriers. It also highlights how top-performing field leaders build payer-process fluency and office-ecosystem intelligence to accelerate time-to-first-script, reduce abandonment, and reinforce payer value narratives. The result is a practical roadmap for Market Access executives to build scalable, future-ready pull-through models that drive speed, consistency, and measurable patient impact across the access journey.